De beoordeling van nieuwe geneesmiddelen. Article in Pharmaceutisch weekblad 3(1) Henk Buurma at Independent Researcher. Henk Buurma. Buy Het juiste medicijn: ruim geneesmiddelen kritisch beoordeeld 01 by Marcel Bouvy, Henk Buurma (ISBN: ) from Amazon’s Book Store. Buurma, H., Jong-van den Berg, L.T.W. de, Leufkens, H.G.M., Het geneesmiddel, Wetenschappelijke uitgeverij Bunge, Utrecht Callon, M, Law, J., Rip, A.

Author: Zolocage Mikagore
Country: Germany
Language: English (Spanish)
Genre: Music
Published (Last): 13 July 2008
Pages: 462
PDF File Size: 1.14 Mb
ePub File Size: 20.96 Mb
ISBN: 937-3-80823-371-6
Downloads: 67352
Price: Free* [*Free Regsitration Required]
Uploader: Mugal

Voorschrijven van geneesmiddelen Haaijer-Ruskamp, F. Outcome prioritisation tool for medication review in older patients with multimorbidity: Efficient selection of older patients for medication review: Prescribing quality indicators of type 2 diabetes mellitus ambulatory care Martirosyan, L. Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?

Journal of the American Medical Informatics Association.

Evaluating an educational intervention to inprove the treatment of asthma in four European countries Veninga, C. Amsterdam Medical Pressp. Claims in advertisements for anti hypertensive drugs in a Dutch medical journal Greving, J. Healthcare quality improvement programme improves monitoring of people with diabetes Denig, P.


Scope and nature of prescribing decisions made by general practitioners Denig, P. Is guideline-adherent prescribing associated with quality of life in patients with type 2 diabetes?

Effects of the occurrence of buurmw first cardiovascular event on statin adherence in type 2 diabetes: Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: Variations in asthma treatment in five European countries: Methods to identify the target population: The decision process of the physician Denig, P.

Succes- en faalfactoren voor implementatie in de praktijk. Gender differences in adverse drug reaction reports; How can they be explained? International Journal for Quality in Health Care. United Kingdon Drug UtilisationVol.

Gender differences in drug-Adverse drug reaction combinations reported to the national pharmacovigilance centre in the Netherlands de Vries, S. Elsevier Gezondheidszorgp. Patient attitudes towards deprescribing of alpha-blockers and willingness to participate in a discontinuation trial Edelman, M. Exploring the role of medication beliefs and perceptions De Smedt, R. About us How to find us prof. Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in geneesmisdel patients: Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands Alfian, S.


There was a problem providing the content you requested

Development and validation of eht quality indicators for patients with type 2 diabetes Smits, K. Investigating decision-making by prescribers Denig, P. A matched cohort design De Vries, F. Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes Voorham, J.

Petra Denig – Research database – University of Groningen

Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands de Vries, F. A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators Martirosyan, L. Trends in prescribing for heart failure in Dutch primary care from to Pont, L.

New renal guidelines; genesmiddel more better?